Digital Health Implementation Strategies to Improve Lung Cancer Screening Among Safety-Net Clinics (LUNG-IS)
Digital Health Implementation Strategies to Improve Lung Cancer Screening Among Safety-Net Clinics (LUNG-IS) - PATIENT
The long-term goal of this program of research is to increase the reach of Lung Cancer Screening (LCS) among low-resource healthcare settings and populations. The proposed project, LUNG-IS, is a mixed-methods, pre-post quasi-experimental design conducted in three Utah safety-net healthcare system clinics.
LUNG-IS employs a comprehensive conceptual model with theories, models, and frameworks of implementation and behavioral science, uses rigorous mixed-methods to evaluate factors that influence implementation of LCS, and uses patient navigation to facilitate clinic-community linkages.
LUNG-IS leverages existing pathways to care and Centralized Hub infrastructure that enables eligibility assessment, LCS Shared Decision Making (SDM) with clinical decision support, screening referral, and screening logistics assistance to help overcome barriers to LCS completion. The Centralized Hub model uses ubiquitous technologies (i.e., text messaging/telehealth) to enable patients to be assessed for LCS eligibility, engage in SDM if eligible, and be referred for LCS. For patients who decide to complete LCS, they will be provided patient navigation via Community Health Workers designed to address logistical barriers, hesitancy, and financial constraints around completing LCS.
Studie Overzicht
Toestand
Conditie
Studietype
Inschrijving (Geschat)
Fase
- Niet toepasbaar
Contacten en locaties
Studiecontact
- Naam: Indy Li, MS
- Telefoonnummer: 801-213-5697
- E-mail: indy.li@hci.utah.edu
Studie Locaties
-
-
Utah
-
Salt Lake City, Utah, Verenigde Staten, 84112
- Werving
- Huntsman Cancer Institute/ University of Utah
-
Contact:
- Indy Li, MS
- Telefoonnummer: 801-213-5697
- E-mail: indy.li@hci.utah.edu
-
Hoofdonderzoeker:
- Chelsey Schlechter, MPH, PhD
-
-
Deelname Criteria
Geschiktheidscriteria
Leeftijden die in aanmerking komen voor studie
- Volwassen
- Oudere volwassene
Accepteert gezonde vrijwilligers
Beschrijving
Inclusion Criteria:
- Current or former, male and female, smokers.
- Age 50-80.
- Primary language English or Spanish.
- Have a phone that can send/receive text messages.
Exclusion Criteria:
- Patients who have never smoked.
- Patients who are under the age of 50 or above the age of 80.
- Primary language other than English or Spanish.
- Do not have access to a phone that can send/receive text messages.
Studie plan
Hoe is de studie opgezet?
Ontwerpdetails
- Primair doel: Preventie
- Toewijzing: Niet-gerandomiseerd
- Interventioneel model: Opdracht voor een enkele groep
- Masker: Geen (open label)
Wapens en interventies
Deelnemersgroep / Arm |
Interventie / Behandeling |
|---|---|
|
Ander: Stage 1: TM+
Basic text messages sent directly to the patient's cell phone.
|
Basic text messages sent directly to the patient's cell phone.
|
|
Ander: Stage 1: TM+, CA
Basic text messages sent directly to the patient's cell phone.
Also includes the option for chat bot to answer frequently asked LCS questions.
|
Basic text messages sent directly to the patient's cell phone.
Chat bot to answer frequently asked LCS questions.
|
|
Ander: Stage 1: TM+, Video
Basic text messages sent directly to the patient's cell phone.
Also includes the option for an educational video about LCS.
|
Basic text messages sent directly to the patient's cell phone.
Educational video about LCS.
|
|
Ander: Stage 1: TM+, CA, Video
Basic text messages sent directly to the patient's cell phone. Also includes the option for chat bot to answer frequently asked LCS questions and option for educational video about LCS. Patients who complete SDM and are referred to LCS will also be assigned to one of the following conditions. Descriptions of these conditions are as follows: |
Basic text messages sent directly to the patient's cell phone.
Chat bot to answer frequently asked LCS questions.
Educational video about LCS.
|
|
Ander: Stage 2: TM+, RPN
Patients who complete SDM and are referred to LCS may be assigned to this condition Patients will receive basic text messages and reactive patient navigation to help get to the LCS appointment. |
Basic text messages sent directly to the patient's cell phone.
Reactive patient navigation to help get to the LCS appointment.
|
|
Ander: Stage 2:TM+, PPN
Patients who complete SDM and are referred to LCS may be assigned to this condition Patients will receive basic text messages and proactive patient navigation to help get to the LCS appointment. Patients who need transportation financial assistance will receive transportation vouchers to help get them to and from their LCS appointment. |
Basic text messages sent directly to the patient's cell phone.
Proactive patient navigation to help get to the LCS appointment.
|
Wat meet het onderzoek?
Primaire uitkomstmaten
Uitkomstmaat |
Maatregel Beschrijving |
Tijdsspanne |
|---|---|---|
|
Impact of Implementation Strategies on Lung Cancer Screening (LCS) eligibility screening
Tijdsspanne: up to 15 weeks after study enrollment
|
Evaluate the impact of implementation strategies on Lung Cancer Screening (LCS) eligibility screening.
This outcome measure will report the proportion of participants who complete LCS eligibility screening.
|
up to 15 weeks after study enrollment
|
Secundaire uitkomstmaten
Uitkomstmaat |
Maatregel Beschrijving |
Tijdsspanne |
|---|---|---|
|
Impact of Implementation Strategies on LCS Shared Decision Making (SDM) completion
Tijdsspanne: up to 7 weeks after completion of LCS eligibility screen
|
Evaluate the impact of implementation strategies on Shared Decision Making (SDM) completion.
This outcome measure will report the proportion of patients who complete SDM.
|
up to 7 weeks after completion of LCS eligibility screen
|
|
Impact of Implementation Strategies on LCS Completion
Tijdsspanne: up to 6 months after placement of LCS referral
|
Evaluate the impact of implementation strategies on LCS completion.
This outcome measure will report the proportion of participants who complete LCS.
|
up to 6 months after placement of LCS referral
|
Medewerkers en onderzoekers
Sponsor
Medewerkers
Onderzoekers
- Hoofdonderzoeker: Chelsey Schlechter, MPH, PhD, Huntsman Cancer Institute/ University of Utah
Studie record data
Bestudeer belangrijke data
Studie start (Werkelijk)
Primaire voltooiing (Geschat)
Studie voltooiing (Geschat)
Studieregistratiedata
Eerst ingediend
Eerst ingediend dat voldeed aan de QC-criteria
Eerst geplaatst (Werkelijk)
Updates van studierecords
Laatste update geplaatst (Werkelijk)
Laatste update ingediend die voldeed aan QC-criteria
Laatst geverifieerd
Meer informatie
Termen gerelateerd aan deze studie
Aanvullende relevante MeSH-voorwaarden
Andere studie-ID-nummers
- 187448
- 1U48DP006855-01 (Subsidie/contract van de Amerikaanse NIH)
Plan Individuele Deelnemersgegevens (IPD)
Bent u van plan om gegevens van individuele deelnemers (IPD) te delen?
Informatie over medicijnen en apparaten, studiedocumenten
Bestudeert een door de Amerikaanse FDA gereguleerd geneesmiddel
Bestudeert een door de Amerikaanse FDA gereguleerd apparaatproduct
Deze informatie is zonder wijzigingen rechtstreeks van de website clinicaltrials.gov gehaald. Als u verzoeken heeft om uw onderzoeksgegevens te wijzigen, te verwijderen of bij te werken, neem dan contact op met register@clinicaltrials.gov. Zodra er een wijziging wordt doorgevoerd op clinicaltrials.gov, wordt deze ook automatisch bijgewerkt op onze website .